Obesity Management Market: Segment Snapshot and Table of Content 2017-2027

Future Market Insights’ latest publication estimates that the global market for obesity management will showcase an average growth during the forecast period, 2017-2027. In this period, the market is estimated to grow from US$ 641.6 Mn in 2016 to US$ 1,078.9 by 2027-end, representing a value CAGR of 4.9%. Between 2017 and 2027, the global obesity management market is poised to witness an incremental $ opportunity of over US$ 400 Mn.

Segmentation highlights

Bupropion and Naltrexone drug type segment anticipated to witness the highest CAGR

While Orlistat dominates the global obesity management market by drug type at present with an estimated market value of more than US$ 200 Mn in 2017, it is poised to record the lowest CAGR of only 1.5% during the decade 2017-2027. On the other hand, Bupropion and Naltrexone is predicted to grow at a massive 8.3% CAGR for the decade, pushing it to a market value of nearly US$ 109 Mn by 2027, as opposed to just under US$ 46 Mn in 2016. An absolute dollar opportunity of roughly US$ 3.6 Mn can be reasonably expected in the Bupropion and Naltrexone segment of the global obesity management market in 2018 over the previous year.

Report Overview @ https://www.futuremarketinsights.com/reports/obesity-management-market

A regional analysis of global obesity management market, compiled in the report, projects that North America’s share on global revenues will surpass 33% towards the end of 2027. North America is anticipated to emerge as the largest market for obesity management in the world. Western Europe will also be at the forefront, bringing in an estimated US$ 222 Mn in revenues by 2027-end. Across different regions in the world, a majority of obesity management drugs will be distributed through hospital pharmacies. With more than 50% share in global revenues, hospital pharmacies will remain the largest distribution channel for obesity management drugs throughout the forecast period.

Request to Sample Report - https://www.futuremarketinsights.com/reports/sample/rep-gb-587

Summary of Table of Content
1. Executive Summary
2. Market Introduction
3. Global Obesity Management Market Analysis Scenario
4. Market Dynamics
5. Global Obesity Management Market Analysis and Forecasts, By Drug Type
6. Global Obesity Management Market Analysis and Forecasts, By Surgery Type
7. Global Obesity Management Market Analysis and Forecasts, By Distribution Channel
8. Global Obesity Management Market Analysis and Forecasts, By Region
9. North America Global Obesity Management Market Analysis and Forecast
10. Latin America Global Obesity Management Market Analysis and Forecast
11. Western Europe Global Obesity Management Market Analysis and Forecast
12. Eastern Europe Global Obesity Management Market Analysis and Forecast
13. APEJ Global Obesity Management Market Analysis and Forecast
14. Japan Global Obesity Management Market Analysis and Forecast
15. MEA Global Obesity Management Market Analysis and Forecast
16. Competition Landscape
17. Assumptions and Acronyms Used
18. Research Methodology

Request to Browse Full Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/obesity-management-market/toc

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.